INJECTAFER is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency BASKING RIDGE, N.J. & SHIRLEY, N.Y.–(BUSINESS WIRE)–Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group […]
